Collectively, these in vitro data confirm the notion that EMX2 down-regulation in colorectal cancer cells affects their migratory potential, thus contributing to an increased rate of distant metastasis and unfavorable outcome. This evidence concerns the gene EMX2 and colorectal cancer.